Related Experiment Video
Updated: Mar 17, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Constrictive Pericarditis and Effusive Constrictive Pericarditis: Is There a Role for Medical Therapy?
Lamis El Harake1, Mohamed Al-Kazaz2, Paul C Cremer2
1Bluhm Cardiovascular Institute, Division of Cardiology, Chicago, Illinois, USA.
Insights
Constrictive pericarditis (CP) involves impaired heart filling due to a stiff pericardium. Early anti-inflammatory treatment can reverse active inflammation and constrictive physiology.
Area of Science:
- Cardiology
- Pericardial Diseases
Background:
- Constrictive pericarditis (CP) is a spectrum of pericardial diseases impairing ventricular filling.
- Effusive constrictive pericarditis (ECP) and transient constrictive pericarditis involve active inflammation.
- Causes include idiopathic, post-surgical, autoimmune, or tuberculous origins, potentially progressing to chronic constrictive pericarditis.
Purpose of the Study:
- To review the diagnosis and management of constrictive pericarditis.
- To highlight the role of multimodality imaging in assessing inflammation and guiding treatment.
- To emphasize the benefits of early, combined anti-inflammatory therapy for active pericardial inflammation.
Main Methods:
- Multimodality imaging: echocardiography, cardiac MRI, cardiac CT.
- Assessment of pericardial inflammation.
- Review of anti-inflammatory treatment strategies.
Main Results:
- Constrictive pericarditis presents a spectrum from transient to chronic forms.
- Active inflammation is key in ECP and transient forms.
- Early anti-inflammatory therapy can reverse constrictive pathophysiology.
Conclusions:
- Multimodality imaging is crucial for diagnosing and managing CP.
- Early and combined anti-inflammatory therapy is supported for active pericardial inflammation.
- Treatment aims to reverse constrictive pathophysiology and improve outcomes.
Abstract:
Constrictive pericarditis (CP) represents a spectrum of pericardial diseases characterized by impaired ventricular filling due to a noncompliant pericardium. Within this continuum, effusive constrictive pericarditis (ECP) and transient constrictive pericarditis are characterized by active inflammation. ECP combines pericardial effusion and constrictive physiology, whereas transient constrictive pericarditis is characterized by resolution, often after anti-inflammatory therapy. These conditions often result from idiopathic, post-surgical, autoimmune, or tuberculous causes and may progress from acute inflammation to chronic fibrosis and calcification, termed chronic constrictive pericarditis. Multimodality imaging, including echocardiography, cardiac magnetic resonance imaging, and cardiac computed tomography, plays a key role in establishing the diagnosis, assessing inflammation, and guiding treatment. In patients with active pericardial inflammation, increasing evidence and practice supports the early and combined initiation of anti-inflammatory therapy including nonsteroidal agents, colchicine, corticosteroids, and interleukin-1 inhibitors to reverse constrictive pathophysiology.
Related Concept Videos
Pericarditis III: Medical Management
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Pericarditis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Pericarditis I: Introduction

